244 related articles for article (PubMed ID: 12070657)
1. Caspase-cleaved amyloid precursor protein and activated caspase-3 are co-localized in the granules of granulovacuolar degeneration in Alzheimer's disease and Down's syndrome brain.
Su JH; Kesslak JP; Head E; Cotman CW
Acta Neuropathol; 2002 Jul; 104(1):1-6. PubMed ID: 12070657
[TBL] [Abstract][Full Text] [Related]
2. Relation of hippocampal phospho-SAPK/JNK granules in Alzheimer's disease and tauopathies to granulovacuolar degeneration bodies.
Lagalwar S; Berry RW; Binder LI
Acta Neuropathol; 2007 Jan; 113(1):63-73. PubMed ID: 17089132
[TBL] [Abstract][Full Text] [Related]
3. A short cytoplasmic domain of the amyloid precursor protein induces apoptosis in vitro and in vivo.
Bertrand E; Brouillet E; Caillé I; Bouillot C; Cole GM; Prochiantz A; Allinquant B
Mol Cell Neurosci; 2001 Nov; 18(5):503-11. PubMed ID: 11922141
[TBL] [Abstract][Full Text] [Related]
4. A second cytotoxic proteolytic peptide derived from amyloid beta-protein precursor.
Lu DC; Rabizadeh S; Chandra S; Shayya RF; Ellerby LM; Ye X; Salvesen GS; Koo EH; Bredesen DE
Nat Med; 2000 Apr; 6(4):397-404. PubMed ID: 10742146
[TBL] [Abstract][Full Text] [Related]
5. Activation of caspase-3 in single neurons and autophagic granules of granulovacuolar degeneration in Alzheimer's disease. Evidence for apoptotic cell death.
Stadelmann C; Deckwerth TL; Srinivasan A; Bancher C; Brück W; Jellinger K; Lassmann H
Am J Pathol; 1999 Nov; 155(5):1459-66. PubMed ID: 10550301
[TBL] [Abstract][Full Text] [Related]
6. Tipping the apoptotic balance in Alzheimer's disease: the abortosis concept.
Raina AK; Zhu X; Shimohama S; Perry G; Smith MA
Cell Biochem Biophys; 2003; 39(3):249-55. PubMed ID: 14716079
[TBL] [Abstract][Full Text] [Related]
7. Activated double-stranded RNA-dependent protein kinase and neuronal death in models of Alzheimer's disease.
Page G; Rioux Bilan A; Ingrand S; Lafay-Chebassier C; Pain S; Perault Pochat MC; Bouras C; Bayer T; Hugon J
Neuroscience; 2006; 139(4):1343-54. PubMed ID: 16581193
[TBL] [Abstract][Full Text] [Related]
8. Sequestration of tau by granulovacuolar degeneration in Alzheimer's disease.
Bondareff W; Wischik CM; Novak M; Roth M
Am J Pathol; 1991 Sep; 139(3):641-7. PubMed ID: 1909492
[TBL] [Abstract][Full Text] [Related]
9. Characterization of Abeta11-40/42 peptide deposition in Alzheimer's disease and young Down's syndrome brains: implication of N-terminally truncated Abeta species in the pathogenesis of Alzheimer's disease.
Liu K; Solano I; Mann D; Lemere C; Mercken M; Trojanowski JQ; Lee VM
Acta Neuropathol; 2006 Aug; 112(2):163-74. PubMed ID: 16865398
[TBL] [Abstract][Full Text] [Related]
10. Activation of caspase-8 in the Alzheimer's disease brain.
Rohn TT; Head E; Nesse WH; Cotman CW; Cribbs DH
Neurobiol Dis; 2001 Dec; 8(6):1006-16. PubMed ID: 11741396
[TBL] [Abstract][Full Text] [Related]
11. Cell death induced by a caspase-cleaved transmembrane fragment of the Alzheimer amyloid precursor protein.
Nishimura I; Uetsuki T; Kuwako K; Hara T; Kawakami T; Aimoto S; Yoshikawa K
Cell Death Differ; 2002 Feb; 9(2):199-208. PubMed ID: 11840170
[TBL] [Abstract][Full Text] [Related]
12. Neuroscience. New leads on the 'how' of Alzheimer's.
Marx J
Science; 2001 Sep; 293(5538):2192-4. PubMed ID: 11567120
[No Abstract] [Full Text] [Related]
13. Caspase inhibition therapy abolishes brain trauma-induced increases in Abeta peptide: implications for clinical outcome.
Abrahamson EE; Ikonomovic MD; Ciallella JR; Hope CE; Paljug WR; Isanski BA; Flood DG; Clark RS; DeKosky ST
Exp Neurol; 2006 Feb; 197(2):437-50. PubMed ID: 16300758
[TBL] [Abstract][Full Text] [Related]
14. Amyloid beta protein toxicity mediated by the formation of amyloid-beta protein precursor complexes.
Lu DC; Shaked GM; Masliah E; Bredesen DE; Koo EH
Ann Neurol; 2003 Dec; 54(6):781-9. PubMed ID: 14681887
[TBL] [Abstract][Full Text] [Related]
15. Chemical and immunological heterogeneity of fibrillar amyloid in plaques of Alzheimer's disease and Down's syndrome brains revealed by confocal microscopy.
Schmidt ML; Robinson KA; Lee VM; Trojanowski JQ
Am J Pathol; 1995 Aug; 147(2):503-15. PubMed ID: 7639340
[TBL] [Abstract][Full Text] [Related]
16. Immunopositivity for ESCRT-III subunit CHMP2B in granulovacuolar degeneration of neurons in the Alzheimer's disease hippocampus.
Yamazaki Y; Takahashi T; Hiji M; Kurashige T; Izumi Y; Yamawaki T; Matsumoto M
Neurosci Lett; 2010 Jun; 477(2):86-90. PubMed ID: 20420883
[TBL] [Abstract][Full Text] [Related]
17. Apoptotic signals within the basal forebrain cholinergic neurons in Alzheimer's disease.
Wu CK; Thal L; Pizzo D; Hansen L; Masliah E; Geula C
Exp Neurol; 2005 Oct; 195(2):484-96. PubMed ID: 16085017
[TBL] [Abstract][Full Text] [Related]
18. Characterization of V642I-AbetaPP-induced cytotoxicity in primary neurons.
Niikura T; Yamada M; Chiba T; Aiso S; Matsuoka M; Nishimoto I
J Neurosci Res; 2004 Jul; 77(1):54-62. PubMed ID: 15197738
[TBL] [Abstract][Full Text] [Related]
19. Frame-shifted amyloid precursor protein found in Alzheimer's disease and Down's syndrome increases levels of secreted amyloid beta40.
van Dijk R; Fischer DF; Sluijs JA; Sonnemans MA; Hobo B; Mercken L; Mann DM; Hol EM; van Leeuwen FW
J Neurochem; 2004 Aug; 90(3):712-23. PubMed ID: 15255950
[TBL] [Abstract][Full Text] [Related]
20. A modified beta-amyloid hypothesis: intraneuronal accumulation of the beta-amyloid peptide--the first step of a fatal cascade.
Wirths O; Multhaup G; Bayer TA
J Neurochem; 2004 Nov; 91(3):513-20. PubMed ID: 15485483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]